肿瘤细胞治疗研究
ALL SOURCES
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.
同时靶向 PD-L1 与 ErbB2 可通过对抗原异质性提供抵抗力并经协同激活放大抗肿瘤信号，增强 CAR-NK 细胞对难治性实体瘤的疗效。
Mechanisms of resistance to antibody-drug conjugates in cancers.
近年来，随着分子靶向药物、单克隆抗体、免疫检查点抑制剂、双特异性抗体和 CAR-T 细胞疗法等多种治疗模式的出现，癌症治疗取得了巨大进展。
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
TNBC 仅占新发乳腺癌诊断的约 15%-20%；
The Three Musketeers in Cancer Therapy: Pharmacokinetics, Pharmacodynamics and Personalised Approach.
癌症治疗正迅速从一刀切的模式向高度个性化的方法演变。
共 5 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
